| Report Title | Price | Action |
|---|---|---|
| Leukotriene B4 (LTB4) - Drugs in Development, 2021
Leukotriene B4 (LTB4) - Drugs in Development, 2021 Summary Leukotriene B4 (LTB4) - Drugs in Development, 2021 provides in depth analysis on Leukotri...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Drugs in Development, 2021
Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Drugs in Development, 2021 Summary Granulocyte...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021
Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Schistosomiasis mansoni Infections (Infectious Disease) - Drugs in Development, 2021
Schistosomiasis mansoni Infections (Infectious Disease) - Drugs in Development, 2021 Summary Schistosomiasis mansoni Infections (Infectious Disease)...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021
Relapsing Multiple Sclerosis (RMS) (Central Nervous System) - Drugs in Development, 2021 Summary Relapsing Multiple Sclerosis (RMS) (Central Nervous...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| High-Grade Glioma (Oncology) - Drugs in Development, 2021
High-Grade Glioma (Oncology) - Drugs in Development, 2021 Summary High-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of ...
Published: Apr-2021 | No. of Pages: 130
|
$ 2000 | |
| Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021
Cells Expressing GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021 Summary Cells Expressing GTPase KRas (...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Tubulin - Drugs in Development, 2021
Tubulin - Drugs in Development, 2021 Summary Tubulin - Drugs in Development, 2021 provides in depth analysis on Tubulin targeted pipeline therapeuti...
Published: Apr-2021 | No. of Pages: 325
|
$ 3500 | |
| Low Affinity Immunoglobulin Gamma Fc Region Receptor III A (Fc Gamma RIII Alpha or IgG Fc Receptor III-2 or CD16a or FCGR3A) - Drugs in Development, 2021
Low Affinity Immunoglobulin Gamma Fc Region Receptor III A (Fc Gamma RIII Alpha or IgG Fc Receptor III-2 or CD16a or FCGR3A) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021
Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021 Summary Thrombopo...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021
Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 Summary Myxoid Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Development, 2021
Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Development, 2021 Summary Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021
Relapsing Remitting Multiple Sclerosis (RRMS) (Central Nervous System) - Drugs in Development, 2021 Summary Relapsing Remitting Multiple Sclerosis (...
Published: Apr-2021 | No. of Pages: 95
|
$ 2000 | |
| Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone Refractory (...
Published: Apr-2021 | No. of Pages: 200
|
$ 2500 | |
| Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021
Cells Expressing Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Summary Cells Expressing Integr...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021
Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021 Summary Human SARS Coronavirus 2 Spike Glycop...
Published: Apr-2021 | No. of Pages: 325
|
$ 3500 | |
| Lysyl Oxidase Homolog 2 (Lysyl Oxidase Like Protein 2 or Lysyl Oxidase Related Protein 2 or Lysyl Oxidase Related Protein WS9-14 or LOXL2 or EC 1.4.3.13) - Drugs in Development, 2021
Lysyl Oxidase Homolog 2 (Lysyl Oxidase Like Protein 2 or Lysyl Oxidase Related Protein 2 or Lysyl Oxidase Related Protein WS9-14 or LOXL2 or EC 1.4.3....
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Drugs in Development, 2021
Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Drugs in Development, 2021 Summary Toll Like Receptor 2 (Toll/I...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
| Pleomorphic Liposarcoma (Oncology) - Drugs in Development, 2021
Pleomorphic Liposarcoma (Oncology) - Drugs in Development, 2021 Summary Pleomorphic Liposarcoma (Oncology) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021
Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021 Summary Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 |